Correction: Parkin ubiquitinates TAR-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6) (Journal of Biological Chemistry (2013) 288(6) (4103–4115), (S0021925820463689), (10.1074/jbc.M112.419945));Parkin ubiquitinates tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6)

Journal of Biological Chemistry

Volumn 288, Issue 6, 2013, Pages 4103-4115

  Hebron, Michaeline L ^a   Lonskaya, Irina ^a   Sharpe, Kaydee ^a   Weerasinghe, Puwakdandawe P K ^a   Algarzae, Norah K ^a   Shekoyan, Ashot R ^a   Moussa, Charbel E H ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE TRANSFER; NEURODEGENERATIVE DISEASES; PLANTS (BOTANY); PROTEINS; TRANSCRIPTION;

CYTOSOLIC; DNA-BINDING PROTEIN; E3 UBIQUITIN LIGASES; HISTONE DEACETYLASES; MISFOLDED PROTEINS; MULTI-PROTEIN COMPLEX; NEURODEGENERATION; NUCLEAR PROTEINS; PROTEIN-PROTEIN INTERACTIONS; WILD TYPES;

NUCLEIC ACIDS;

HISTONE DEACETYLASE 6; LYSINE; MESSENGER RNA; MULTIPROTEIN COMPLEX; MUTANT PROTEIN; PARKIN; TAR DNA BINDING PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARKIN GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; TRANSGENIC MOUSE; UBIQUITINATION;

EID: 84873615689     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1016/j.jbc.2022.102828     Document Type: Erratum

References (77)

1. Ou, S. H., Wu, F., Harrich, D., Garcfa-Martfnez, L. F., and Gaynor, R. B. (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. Virol. 69, 3584-3596
2. Wang, H. Y., Wang, I. F., Bose, J., and Shen, C. K. (2004) Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83, 130-139
3. Hasegawa, M., Arai, T., Nonaka, T., Kametani, F., Yoshida, M., Hashi-zume, Y., Beach, T. G., Buratti, E., Baralle, F., Morita, M., Nakano, I., Oda, T., Tsuchiya, IC, and Akiyama, H. (2008) Phosphorylated TDP-43 in fron-totemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60-70
4. Mackenzie, I. R., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. IC, Forman, M. S., Ravits, J., Stewart, H., Eisen, A., Mc-Clusky, L., Kretzschmar, H. A., Monoranu, C. M., Highley, J. R., Kirby, J., Siddique, T., Shaw, P. J., Lee, V. M., and Trojanowski, J. Q. (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427-434
5. Neumann, M., Kwong, L. IC, Sampathu, D. M., Trojanowski, J. Q., and Lee, V. M. (2007) TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Protein misfolding diseases without amyloidosis. Arch. Neurol. 64, 1388-1394
6. Neumann, M., Mackenzie, I. R., Cairns, N. J., Boyer, P. J., Markesbery, W. R., Smith, C. D., Taylor, J. P., Kretzschmar, H. A., Kimonis, V. E., and Forman, M. S. (2007) TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations, J. Neuropathol. Exp. Neurol. 66, 152-157
7. Neumann, M., Sampathu, D. M., Kwong, L. IC, Truax, A. C, Micsenyi, M. C, Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., McCluskey, L. F., Miller, B. L., Masliah, E., Mackenzie, I. R., Feldman, H., Feiden, W., Kretzschmar, H. A., Trojanowski, J. Q., and Lee, V. M. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133
8. Zhang, Y. J., Xu, Y. F., Cook, C, Gendron, T. F., Roettges, P., Link, C. D., Lin, W. L., Tong, J., Castanedes-Casey, M., Ash, P., Gass, J., Rangachari, V., Buratti, E., Baralle, F., Golde, T. E., Dickson, D. W., and Petrucelli, L. (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sei. U.S.A. 106, 7607-7612
9. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S. M., Iwata, N., Saido, T. C, Maeda, J., Suhara, T., Trojanowski, I. Q., and Lee, V. M. (2007) Synapse loss and microglial activation precede tangles in a P301S tauopa-thy mouse model. Neuron 53, 337-351
10. Leigh, P. N., Whitwell, H., Garofalo, O., Buller, J., Swash, M., Martin, J. E., Gallo, J. M., Weiler, R. O., and Anderton, B. H. (1991) Ubiquitin-immu-noreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114, 775-788
11. Arai, T., Hasegawa, M., Akiyama, H, Ikeda, IC, Nonaka, T., Mori, H, Mann, D., Tsuchiya, IC, Yoshida, M., Hashizume, Y., and Oda, T. (2006) TDP-43 is a component of ubiquitin-positive T-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602-611
12. Mackenzie, I. R., Rademakers, R., and Neumann, M. (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 9, 995-1007
13. Gitcho, M. A., Baloh, R. H, Chakraverty, S., Mayo, IC, Norton, J. B., Lev-itch, D., Hatanpaa, ICJ., White, C. L., 3rd, Bigio, E.H., Caselli, R., Baker, M., Al-Lozi, M. T., Morris, I. C, Pestronk, A., Rademakers, R., Goate, A. M., and Cairns, N. J. (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 63, 535-538
14. Yokoseki, A., Shiga, A., Tan, C. F., Tagawa, A., Kaneko, H, Koyama, A., Eguchi, H, Tsujino, A., Ikeuchi, T., Kakita, A., Okamoto, IC, Nishizawa, M., Takahashi, H, and Onodera, O. (2008) TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 63, 538-542
15. Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Vande Velde, C, Bouchard, J. P., Lacomblez, L., Pochigaeva, IC, Salachas, F., Pradat, P. F., Camu, W., Meininger, V., Dupre, N., and Rouleau, G. A. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574
16. Van Deerlin, V M., Leverenz, J. B., Bekris, L. M., Bird, T. D., Yuan, W., Elman, L. B., Clay, D., Wood, E. M., Chen-Plotkin, A. S., Martinez-Lage, M., Steinbart, E., McCluskey, L., Grossman, M., Neumann, M., Wu, I. L., Yang, W. S., Kalb, R., Galasko, D. R., Montine, T. J., Trojanowski, J. Q., Lee, V. M., Schellenberg, G. D., and Yu, C. E. (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology. A genetic and histopathological analysis. Lancet Neurol. 7, 409-416
17. Sreedharan, J., Blair, I. P., Tripathi, V B., Hu, X., Vance, C, Rogelj, B., Ackerley, S., Durnall, J. C, Williams, IC L., Buratti, E., Baralle, F., de Bel-leroche, J., Mitchell, I. D., Leigh, P. N., Al-Chalabi, A., Miller, C. C, Nicholson, G., and Shaw, C E. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672
18. Geser, F., Robinson, J. L., Malunda, J. A., Xie, S. X., Clark, C. M., Kwong, L. IC, Moberg, P. J., Moore, E. M., Van Deerlin, V M., Lee, V M., Arnold, S. E., and Trojanowski, J. Q. (2010) Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch. Neurol. 67, 1238-1250
19. Schwab, C, Arai, T., Hasegawa, M., Yu, S., and McGeer, P. L. (2008) Colocalizationoftransactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. Neuropathol. Exp. Neu-rol. 67, 1159-1165
20. Hasegawa, M., Arai, T., Akiyama, H., Nonaka, T., Mori, H., Hashimoto, T., Yamazaki, M., and Oyanagi, IC (2007) TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130, 1386-1394
21. Geser, F., Winton, M. J., Kwong, L. IC, Xu, Y., Xie, S. X., Igaz, L. M., Garruto, R. M., Perl, D. P., Galasko, D., Lee, V. M., and Trojanowski, J. Q. (2008) Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol. 115, 133-145
22. Higashi, S., Iseki, E., Yamamoto, R., Minegishi, M., Hino, H, Fujisawa, IC, Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., Kosaka, K., and Arai, H. (2007) Concurrence of TDP-43, T, and a-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res. 1184, 284-294
23. Amador-Ortiz, C, Lin, W. L., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff-Radford, N. R., Hutton, M. L., and Dickson, D.W. (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 61, 435-445
24. King, A., Sweeney, F., Bodi, I., Troakes, C, Maekawa, S., and Al-Sarraj, S. (2010) Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease. Neuropathology 30, 408-419
25. Herman, A. M., Khandelwal, P. J., Stanczyk, B. B., Rebeck, G. W., and Moussa, C. E. (2011) β-Amyloid triggers ALS-associated TDP-43 pathology in AD models. Brain Res. 1386, 191-199
26. Nakashima-Yasuda, H., Uryu, IC, Robinson, J., Xie, S. X., Hurtig, H., Duda, 1. E., Arnold, S. E., Siderowf, A., Grossman, M., Leverenz, J. B., Woltjer, R., Lopez, O. L., Hamilton, R., Tsuang, D. W., Galasko, D., Masliah, E., Kaye, 1., Clark, C. M., Montine, T. J., Lee, V. M., and Trojanowski, J. Q. (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 114, 221-229
27. Uryu, IC, Nakashima-Yasuda, H., Forman, M. S., Kwong, L. IC, Clark, C. M., Grossman, M., Miller, B. L., Kretzschmar, H. A., Lee, V. M., Trojanowski, I. Q., and Neumann, M. (2008) Concomitant TAR-DNA-bind-ing protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J. Neuropathol. Exp. Neurol. 67, 555-564
28. Yokota, O., Davidson, Y., Bigio, E. H, Ishizu, H, Terada, S., Arai, T., Hasegawa, M., Akiyama, H., Sikkink, S., Pickering-Brown, S., and Mann, D. M. (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol. 120, 55-66
29. Polymenidou, M., Lagier-Tourenne, C, Hutt, K. R., Huelga, S. C, Moran, J., Liang, T. Y., Ling, S. C, Sun, E., Wancewicz, E., Mazur, C, Kordasiewicz, H, Sedaghat, Y., Donohue, J. P., Shiue, L., Bennett, C. F., Yeo, G. W., and Cleveland, D.W. (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459-468
30. Lagier-Tourenne, C, Polymenidou, M., Hutt, K. R., Vu, A. Q., Baughn, M., Huelga, S. C, Clutario, K. M., Ling, S. C, Liang, T. Y., Mazur, C, Wancewicz, E., Kim, A. S., Watt, A., Freier, S., Hicks, G. G., Donohue, J. P., Shiue, L., Bennett, C. F., Ravits, J., Cleveland, D. W., and Yeo, G. W. (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 15, 1488-1497
31. Shimura, H., Hattori, N, Kubo Si, Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, IC, and Suzuki, T. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302-305
32. Cookson, M. R., and Bandmann, O. (2010) Parkinson's disease. Insights from pathways. Hum. Mol. Genet. 19, R21-27
33. Kitada, T., Asakawa, S., Hattori, N, Matsumine, H, Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608
34. Lucking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michèle, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., Agid, Y., Brice, A., French Parkinson's Disease Genetics Study Group, and European Consortium on Genetic Susceptibility in Parkinson's Disease (2000) Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl. J. Med. 342, 1560-1567
35. Clark, I. E., Dodson, M. W., Jiang, C, Cao, J. H, Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., and Guo, M. (2006) Drosophila pinkl is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162-1166
36. Greene, J. C, Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., and Pallanck, L. J. (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sei. U.S.A. 100, 4078-4083
37. Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J. M., and Chung, J. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157-1161
38. Staropoli, J. F., McDermott, C, Martinat, C, Schulman, B., Demireva, E., and Abeliovich, A. (2003) Parkin is a component of an SCF-like ubiquitinligase complex and protects postmitotic neurons from kainate excitotox-icity. Neuron 37, 735-749
39. Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, IC I., and Takahashi, R. (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell 10, 55-67
40. Burns, M. P., Zhang, L., Rebeck, G. W., Querfurth, H. W., and Moussa, C. E. (2009) Parkin promotes intracellular A/31-42 clearance. Hum. Mol. Genet. 18, 3206-3216
41. Khandelwal, P. J., Dumanis, S. B., Feng, L. R., Maguire-Zeiss, IC, Rebeck, G., Lashuel, H. A., and Moussa, C. E. (2010) Parkinson-related parkin reduces a-synuclein phosphorylation in a gene transfer model. Mol. Neu-rodegener 5, 47
42. Rosen, K. M., Moussa, C. E., Lee, H. IC, Kumar, P., Kitada, T., Qin, G., Fu, Q., and Querfurth, H. W. (2010) Parkin reverses intracellular β-amyloid accumulation and its negative effects on proteasome function. Neurosci. Res. 88, 167-178
43. Herman, A. M., Khandelwal, P. J., Rebeck, G. W., and Moussa, C. E. (2012) Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models. Exp. Neurol. 235, 297-305
44. Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., and Baloh, R. H. (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sei. U.S.A. 106, 18809-18814
45. Lonskaya, I., Shekoyan, A. R., Hebron, M. L., Desforges, N, Algarzae, N. IC, and Moussa, C. E. (2012) Diminished Parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's Disease, J. Alzheimers Dis. 33, 231-247
46. Hu, G., Zhang, S., Vidal, M., Baer, J. L., Xu, T., and Fearon, E. R. (1997) Mammalian homologs of seven in absentia regulate DCC via the ubiqui-tin-proteasome pathway. Genes Dev. 11, 2701-2714
47. Dickins, R. A., Frew, I. J., House, C. M., O'Bryan, M. IC, Holloway, A. J., Haviv, L, Traficante, N, de Kretser, D. M., and Bowtell, D. D. (2002) The ubiquitin ligase component Siahla is required for completion of meiosis I in male mice. Mol. Cell. Biol. 22, 2294-2303
48. Hu, G., and Fearon, E. R. (1999) Siah-1 N-terminal RING domain is required for proteolysis function, and C-terminal sequences regulate oligo-merization and binding to target proteins. Mol. Cell. Biol. 19, 724-732
49. Qi, J., Pellecchia, M., and Ronai, Z. A. (2010) The Siah2-HIF-FoxA2 axis in prostate cancer-new markers and therapeutic opportunities. Oncotarget 1, 379-385
50. Qi, J., Nakayama, IC, Cardiff, R. D., Borowsky, A. D., Kaul, IC, Williams, R., Krajewski, S., Mercola, D., Carpenter, P. M., Bowtell, D., and Ronai, Z. A. (2010) Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell 18, 23-38
51. Nakayama, IC, Frew, I. J., Hagensen, M., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument-Bromage, H., Tempst, P., Frappell, P. B., Bowtell, D. D., and Ronai, Z. (2004) Siah2 regulates stability of prolyl-hydroxylases, controls HIFla abundance, and modulates physiological responses to hypoxia. Cell 117, 941-952
52. Jiang, Q., Ren, Y., and Feng, J. (2008) Direct binding with histone deacety-lase 6 mediates the reversible recruitment of parkin to the centrosome. Neurosci. 28, 12993-13002
53. Olzmann, J. A., and Chin, L. S. (2008) Parkin-mediated K63-linked poly-ubiquitination. A signal for targeting misfolded proteins to the ag-gresome-autophagy pathway. Autophagy 4, 85-87
54. Yamamoto, A., Friedlein, A., Imai, Y., Takahashi, R., Kahle, P. J., and Haass, C. (2005) Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity. Biol. Chem. 280, 3390-3399
55. Avraham, E., Rott, R., Liani, E., Szargel, R., and Engelender, S. (2007) Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. Biol. Chem. 282, 12842-12850
56. Rubio de la Torre, E., Luzón-Toro, B., Forte-Lago, I., Minguez-Castella-nos, A., Ferrer, I., and Hilfiker, S. (2009) Combined kinase inhibition modulates parkin inactivation. Hum. Mol. Genet. 18, 809-823
57. Ko, H. S., Lee, Y., Shin, J. H., Karuppagounder, S. S., Gadad, B. S., Koleske, A. J., Pletnikova, O., Troncoso, J. C, Dawson, V. L., and Dawson, T. M. (2010) Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc. Natl. Acad. Sei. U.S.A. 107, 16691-16696
58. Imam, S. Z., Zhou, Q., Yamamoto, A., Valente, A. J., Ali, S. F., Bains, M., Roberts, J. L., Kahle, P. J., Clark, R. A., and Li, S. (2011) Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation. Implications for Parkinson's disease. Neurosci. 31, 157-163
59. Kim, Y., Park, J., Kim, S., Song, S., Kwon, S. IC, Lee, S. H., Kitada, T., Kim, J. M., and Chung, J. (2008) PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem. Biophys. Res. Commun. 377, 975-980
60. Sha, D., Chin, L. S., and Li, L. (2010) Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-KB signaling. Hum. Mol. Genet. 19, 352-363
61. Rodriguez-Navarro, J. A., Gomez, A., Rodal, I., Perucho, J., Martinez, A., Furió, V., Ampuero, I., Casarejos, M. J., Solano, R. M., de Yébenes, J. G., and Mena, M. A. (2008) Parkin deletion causes cerebral and systemic amyloidosis in human mutated T over-expressing mice. Hum. Mol. Genet. 17, 3128-3143
62. Peng, J., Schwartz, D., Elias, J. E., Thoreen, C. C, Cheng, D., Marsischky, G., Roelofs, J., Finley, D., and Gygi, S. P. (2003) A proteomics approach to understanding protein ubiquitination. Wat Biotechnol. 21, 921-926
63. Ikeda, F., and Dikic, I. (2008) Atypical ubiquitin chains. New molecular signals. Protein modifications. Beyond the usual suspects' review series. EMBORep. 9, 536-542
64. Seibenhener, M. L., Geetha, T., and Wooten, M. W. (2007) Sequestosome l/p62-more than just a scaffold. F£SS Lett. 581, 175-179
65. Riley, B. E., Kaiser, S. E., Shaler, T. A., Ng, A. C, Hara, T., Hipp, M. S., Lage, IC, Xavier, R. J., Ryu, K. Y., Taguchi, IC, Yamamoto, M., Tanaka, IC, Miz-ushima, N, Komatsu, M., and Kopito, R. R. (2010) Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection. Cell Biol. 191, 537-552
66. Kim, H. T., Kim, K. P., Lledias, F., Kisselev, A.F., Scaglione, K. M., Skowyra, D., Gygi, S. P., and Goldberg, A. L. (2007) Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. Biol. Chem. 282, 17375-17386
67. Tan, J. M., Wong, E. S., Kirkpatrick, D. S., Pletnikova, O., Ko, H. S., Tay, S. P., Ho, M. W., Troncoso, J., Gygi, S. P., Lee, M. K., Dawson, V. L., Dawson, T. M., and Lim, K. L. (2008) Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum. Mol. Genet. 17, 431-439
68. Dickson, D. W., Josephs, K. A., and Amador-Ortiz, C. (2007) TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol. 114, 71-79
69. Geser, F., Brandmeir, N. J., Kwong, L. IC, Martinez-Lage, M., Elman, L., McCluskey, L., Xie, S. X., Lee, V. M., and Trojanowski, I. Q. (2008) Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch. Neurol. 65, 636-641
70. McCluskey, L. F., Elman, L. B., Martinez-Lage, M., Van Deerlin, V., Yuan, W, Clay, D., Siderowf, A., and Trojanowski, J. Q. (2009) Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology. Arch. Neurol. 66, 121-124
71. Mitchell, J. D., and Borasio, G. D. (2007) Amyotrophic lateral sclerosis. Lancet 369, 2031-2041
72. Polymenidou, M., and Cleveland, D. W. (2011) The seeds of neurodegen-eration: prion-like spreading in ALS. Cell 147, 498-508
73. Lagier-Tourenne, C, Polymenidou, M., and Cleveland, D. W. (2010) TDP-43 and FUS/TLS. Emerging roles in RNA processing and neurode-generation. Hum. Mol. Genet. 19, R46-64
74. Fiesel, F. C, Schurr, C, Weber, S. S., and Kahle, P. J. (2011) TDP-43 knockdown impairs neurite outgrowth dependent on its target histone deacetylase 6. Mol. Neurodegener 6, 64
75. Kawahara, IC, Hashimoto, M., Bar-On, P., Ho, G. J., Crews, L., Mizuno, H, Rockenstein, E., Imam, S. Z., and Masliah, E. (2008) a-Synuclein aggregates interfere with Parkin solubility and distribution. Role in the pathogenesis of Parkinson disease. Biol. Chem. 283, 6979-6987
76. Mizuno, Y., Hattori, N, Mori, H, Suzuki, T., and Tanaka, IC (2001) Parkin and Parkinson's disease. Curr. Opin. Neurol. 14, 477-482
77. Tollervey, J. R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., König, J., Hortobâgyi, T., Nishimura, A. L., Zupunski, V., Patani, R., Chan-dran, S., Rot, G., Zupan, B., Shaw, C. E., and Ule, J. (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 14, 452-458